skip to content
   

According to THE SAGE GROUP, Peripheral Artery Disease (PAD) Afflicts 42 to 60 Million
Chinese Citizens


BEAUFORT, SC September 22, 2017 (BUSINESS WIRE)—A new analysis published by THE SAGE GROUP concludes that 5.6 to 6.3 million Chinese suffer from the most severe form of PAD, critical limb ischemia (CLI).

“China is known as the Diabetes Capital of the World,” stated Mary L. Yost, President of THE SAGE GROUP.  “According to our estimates, it is also the PAD Capital of the World with the highest disease prevalence. China likely leads in the number with CLI. We believe that PAD represents a major, underestimated problem for the Chinese economy and healthcare system.”

“Although it is commonly believed that PAD is a ‘Western’ disease with a significantly lower prevalence in Asians, our research indicates this is not the case. One of the key reasons is that there are ethnic differences in the threshold value of ABI, which lead to underestimation of PAD prevalence in countries such as Japan and China,” Yost explained.

Commenting on PAD risk factors in China, Yost observed, “Over the last 20 years, diabetes, hypertension and chronic kidney disease have increased dramatically. Prevalence of these cardiovascular risk factors has risen to levels almost equivalent to the U.S. Although China’s population is currently younger than the U.S., Japan and Western Europe, its population is aging rapidly. Furthermore, the prevalence of smoking, the strongest risk factor for PAD, is considerably higher than in the U.S. and Europe. Exposure to secondhand smoke is widespread.”   

About the Report: China Peripheral Artery Disease and Critical Limb Ischemia Prevalence and Incidence

The report contains a comprehensive analysis of the current prevalence and incidence of PAD and CLI in China. Epidemiology of diabetes, hypertension, chronic kidney disease and smoking and the impact of these risk factors on PAD are detailed. PAD and CLI prevalence and incidence are estimated for 2015-2035 employing the Diabetes Method as well as other risk factors. The number of patients with intermittent claudication (IC) is also included in the analysis of symptomatic disease.

Additional information: http://thesagegroup.us/pages/reports/china-pad-cli.php.

THE SAGE GROUP, a research and consulting company, specializes in peripheral vascular disease in the lower limbs, specifically chronic venous disease (CVD), PAD, CLI, IC, diabetic foot ulcers (DFU) and the costs and consequences of PAD and amputation.  Additional information: www.thesagegroup.us.

SOURCE: THE SAGE GROUP


THE SAGE GROUP, Beaufort SC

Harrington Witherspoon, (404) 816-0746
witherspoon@thesagegroup.us

 

 

 

 

 

 

 

Powered by Website Baker, design by Atlanta Based MaxxWebs Design and Development